OUR COMPANY
We’re the Company Behind OPTAVIAOPTAVIA
Medifast is the company behind one of the fastest-growing health and wellness communities, OPTAVIAOPTAVIA, which offers scientifically developed products, clinically proven plans and the support of independent OPTAVIAOPTAVIA Coaches to help Customers achieve Lifelong Transformation, One Healthy Habit at a Time.
OUR APPROACH
3 Million Lives Impacted
Medifast has impacted more than 3 million lives through its Community of OPTAVIAOPTAVIA Coaches, who teach Customers how to develop holistic healthy habits through the proprietary Habits of Health® Transformational System. Today, we are the market leader, by revenue, in the United States $7 billion weight management industry and publicly traded under MED on the New York Stock Exchange.
OUR APPROACH
2 Million Lives Impacted
LEADERSHIP
“We’re a mission-driven organization that is making a real difference. In partnership with our independent OPTAVIAOPTAVIA Coaches, we’re leading a movement that’s changing the paradigm of health and wellness as we know it. People are craving a holistic, supportive approach to managing health and wellbeing, and our Coaches are delivering just that.”
— Dan Chard, Chairman and Chief Executive Officer
LEADERSHIP
— Dan Chard, Chairman and Chief Executive Officer
AT A GLANCE
A Differentiated and Unique Model Centered on Independent OPTAVIAOPTAVIA Coaches
Company Performance
Fourth Quarter 2024 Highlights
This was an important year for Medifast, as we continued to transform our business to meet the changing nature of a health and wellness market that has been revolutionized by the rising acceptance of GLP-1 weight loss medications. As we look ahead, we believe our efforts will broaden our reach, restore revenue and profitability growth and deliver long-term value to all our stakeholders.
Company Performance
GLP-1 User Discontinuation
Medifast addresses the full spectrum of consumer needs in today’s weight loss market – whether customers are pursuing habit-based approaches, on GLP-1s or transitioning off the medications. With up to 74% of GLP-1 users discontinuing medications within 12 months, OPTAVIA provides science-backed solutions that can set customers up for success. A comprehensive approach is critical, and we’re delivering it.
Company Performance
Fuel For The Future
Through our Fuel for the Future initiative, Medifast delivered $21M in cost savings in 2024, exceeding our initial targets. In 2025, we expect to unlock an additional $15-$20M in savings as we continue optimizing our operations.** These efficiencies allow us to reinvest in key growth areas while maintaining financial strength. A disciplined approach today fuels sustainable growth for the future.
Company Performance
OPTAVIA Programs for Each Customer Segment
Medifast is entering 2025 with a focused strategy to drive growth in an evolving weight management market. This year, we’re doubling down on:
- Scaling customer growth through targeting marketing and coach-driven efforts to attract new customers and reactive lapsed customers.
- Improving coach productivity by scaling best practices of high-performing teams and leveraging new coach education resources.
- Advancing clinical research on OPTAVIA customers, focusing on GLP-1 medication use, lean muscle retention, and long-term weight maintenance.
- Expanding our product offering with new products that enhance our introductory product offer.
- Exploring broadening our portfolio into new health categories to address consumer needs.




YEARS OF EXPERIENCE
40+ years
Backed by more than 40 years of experience, clinically proven plans, innovative products and a powerful integrated Coach model, Medifast is the publicly traded market leader by revenue in the U.S. $7 billion weight management industry. Our business model is differentiated and unique — a scalable Coach-based approach that drives both program effectiveness and company growth.
LIVES IMPACTED
3 million
OPTAVIAOPTAVIA Coaches have impacted more than 3 million lives, supporting Clients in their journeys to optimal health and wellbeing.
HEALTHCARE RECOMMENDATIONS
Thousands
As a leader in the health and wellness industry, our clinically proven plans and scientifically designed products have been recommended to Clients for decades.
ACTIVE EARNING COACHES
Tens of Thousands
Medifast has built a network of thousands of independent active earning coaches who impact lives.
Medifast is founded, having created a proprietary formula for meal replacements distributed exclusively through doctors.
As a testament to its significant growth and success, the company goes public for the first time on the American Stock Exchange (AMEX). In 2006, Medifast joins the New York Stock Exchange (NYSE) as it continues to grow in sales and earnings.
Medifast launches the 5 & 1 Plan along with the Lean & Green meal that offers an endless variety of protein and fresh veggie options to help Clients reach optimal health in delicious, new ways. The clinically proven Plan and scientifically designed products were developed by physicians, dietitians and scientists.
With Dr. A’s Habits of Health Transformational System, Clients learn to create healthy habits through small, daily changes called microHabits – often starting with achieving a healthy weight and focusing on healthy eating. It isn’t only about the food you eat, though. The program also addresses hydration, exercise, sleep, mindfulness and surroundings – with the goal of healthy habit creation in all areas of life.
There are three fundamental truths that we believe to be true: People are more successful in their health journey when they (1) have help from a Coach, (2) have the support of a Community and (3) incorporate healthy habits into their lives. These insights brought about the evolution of our brand and how we support people in their journey, now exclusively through the OPTAVIAOPTAVIA integrated Coach model.
*Appel, L.J., et al., Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med, 2011. 365(21): p. 1959-68; Harrigan, M., et al., Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study. J Clin Oncol, 2016. 34(7): p. 669-76; van Wier M.F., et al., Phone and e-mail counselling are effective for weight management in an overweight working population: a randomized controlled trial. BMC Public Health, 2009. 9: 6; and Donnelly, J.E., et al., Comparison of a phone vs clinic approach to achieve 10% weight loss. Int J Obes (Lond), 2007. 31(8): p. 1270-6
SCIENTIFIC ADVISORY BOARD
Internationally Recognized Experts in Science and Health & Wellness
Medifast first formed their Scientific Advisory Board in 2008. It is comprised of internationally recognized experts, all of whom have made significant contributions in their respective field. The function of the Scientific Advisory Board is to provide objective insight and external expertise to help guide Medifast in making informed, evidence-based decisions on medical, nutritional and scientific matters. The Scientific Advisory Board serves as a part of our foundation to create scientifically valid, consumer-centric, high-quality innovations for lasting health.
This cross-disciplinary group consists of distinguished physicians, academic researchers, nutrition and health-related policy experts. The work of this prestigious board builds on Medifast’s scientific and clinical heritage, which focuses on sound approaches to weight management while exploring forward-looking innovations, product and program offerings, and clinical research opportunities.






**This website contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as “intend,” “anticipate,” “expect” or other similar words or the negative of such terminology. Similarly, descriptions of Medifast’s objectives, strategies, plans, goals, outlook or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of the management of Medifast and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Medifast’s inability to maintain and grow the network of independent OPTAVIA Coaches; Industry competition and new weight loss products, including weight loss medications, or services; Medifast’s health or advertising related claims by our OPTAVIA customers; effectiveness of Medifast’s advertising and marketing programs, including use of social media by OPTAVIA Coaches; Medifast’s inability to protect against online security risks and cyberattacks; risks associated with Medifast’s direct-to-consumer business model; disruptions in Medifast’s supply chain; Medifast’s planned growth into domestic markets; adverse publicity associated with Medifast’s products; the impact of existing and future laws and regulations on Medifast’s business; fluctuations of Medifast’s common stock market price; increases in litigation; actions of activist investors; the consequences of other geopolitical events, overall economic and market conditions and the resulting impact on consumer sentiment and spending patterns; and Medifast’s ability to prevent or detect a failure of internal control over financial reporting. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its most recent Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its quarterly reports on Form 10-Q and current reports on Form 8-K.